Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
0 hedge funds and large institutions have $0 invested in Icosavax, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 93 closing their positions.
100% less funds holding
Funds holding: 93 → 0 (-93)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $664M → $0 (-$664M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 93
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$94M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$61.9M |
| 3 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$58.4M |
| 4 |
QUSVM
Qiming U.S. Ventures Management
Bellevue,
Washington
|
-$55.3M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$47.3M |
ICVX Hedge Fund Activity: Q1 2024 in Review
0 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q1 2024, worth a combined $0 — down 100% from $664M a quarter earlier.
Sellers outnumbered buyers: 93 funds closed out of ICVX and 0 opened new positions — a net loss of 93 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was RA Capital Management, exiting entirely with an estimated $94M sold.
- 0 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q1 2024, down from 93 in Q4 2023.
- Funds reported $0 of Icosavax, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Icosavax, Inc. Common Stock positions in Q1 2024 and 93 closed out, a net change of -93 holders.
- The largest Icosavax, Inc. Common Stock seller in Q1 2024 was RA Capital Management, an estimated $94M sold.
Based on aggregated 13F filings for Q1 2024.